Carlsmed, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
Carlsmed, Inc. (CARL) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $700.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-08-05
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-06-30 was $700.00K, a 133.33% increase year-over-year.
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-03-31 was $402.00K, a 673.08% increase year-over-year.
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $52.00K, a 10.34% decline year-over-year.
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $414.00K, a 12.50% increase from fiscal 2024.
- Carlsmed, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $368.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-06-30 | $700.00K 10-Q · filed 2026-08-05 | $1.14M 10-Q · filed 2026-08-05 | $1.15M derived: sum of 3 quarters · filed 2026-08-05 | $1.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $402.00K 10-Q · filed 2026-05-05 | $454.00K derived: sum of 2 quarters · filed 2026-05-05 | $554.00K derived: sum of 3 quarters · filed 2026-05-05 | $854.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $152.00K derived: sum of 2 quarters · filed 2026-02-25 | $452.00K derived: sum of 3 quarters · filed 2026-08-05 | $414.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-06 | $400.00K derived: sum of 2 quarters · filed 2026-08-05 | $362.00K 10-Q · filed 2025-11-06 | $510.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-05 | $338.00K 10-Q · filed 2026-08-05 | $410.00K derived: sum of 3 quarters · filed 2026-08-05 | $510.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $52.00K 10-Q · filed 2026-05-05 | $110.00K derived: sum of 2 quarters · filed 2026-05-05 | $210.00K derived: sum of 3 quarters · filed 2026-05-05 | $310.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $158.00K derived: sum of 2 quarters · filed 2026-02-25 | $258.00K derived: sum of 3 quarters · filed 2026-02-25 | $368.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-06 | $200.00K derived: sum of 2 quarters · filed 2025-11-06 | $310.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-28 | $200.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |